Forte Biosciences, Inc. (FBRX) Shareholders’ equity 2016–2019
Forte Biosciences, Inc. (FBRX) shareholders’ equity at each fiscal year-end, per SEC filings.
-$4.8MFY2019 · since FY2016: -$124.4M → -$4.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | -$4.8M | -548.0% |
| FY2018 | -$736,000 | -101.0% |
| FY2017 | $71.1M | +157.1% |
| FY2016 | -$124.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice